![Konstantinos Xynos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/05/2026
Konstantinos Xynos currently works at Replimune Group, Inc., as Chief Medical Officer from 2022.
Dr. Xynos also formerly worked at Deciphera Pharmaceuticals, Inc., as Vice President & Head-Global Medical Affairs from 2019 to 2021.
Dr. Xynos received his undergraduate degree in 1991 from the University of Illinois, Masters Business Admin degree in 2013 from the University of Strathclyde, doctorate degree in 1997 from Aristotle University of Thessaloniki, and doctorate degree in 2012 from National & Kapodistrian University of Athens.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/05/2026 | 235.662 ( 0,3% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| REPLIMUNE GROUP, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2022 |
| Società | Posizione | Fine |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aristotle University of Thessaloniki
 Aristotle University of Thessaloniki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National & Kapodistrian University of Athens
 National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
